Kathryn C. Zoon, Director at Emergent BioSolutions Inc. (EBS), sold 3,530 shares at $8.38 ($30K) on 2023-05-25, disclosed to the SEC on 2023-07-24.
Scheduled sale ($30k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.38 | 1,700 | $14K | 48.2% |
| 2 | $8.35 | 1,830 | $15K | 51.8% |
| Total | $8.36 avg | 3,530 | $30K | 100% |
| Filing → |
| EBS | SELL | 2025-03-12 | $115K | — | Filing → |
| EBS | SELL | 2024-06-06 | $61K | — | Filing → |
| EBS | SELL | 2024-05-31 | $8K | — | Filing → |